REG - Oxford Nanopore Tech - Seeks discovery into expected breach of contract

Oxford Nanopore TechnologiesAnnouncement

10/09/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240910:nRSJ5077Da&default-theme=true

RNS Number : 5077D  Oxford Nanopore Technologies plc  10 September 2024

10 September 2024

Oxford Nanopore Technologies plc

Oxford Nanopore seeks discovery in connection with anticipated breach of
contract action

Oxford Nanopore Technologies plc (LSE: ONT) ("Oxford Nanopore" or "the
Group"), the company delivering a new generation of nanopore-based molecular
sensing technology, today announces that it has filed an ex parte application
under 28 U.S.C. § 1782 in the U.S. District Court for the Northern District
of California, for leave to serve subpoenas on Complete Genomics, Inc.,
Innomics Inc. (formerly known as BGI Americas Corp.), MGI Americas, Inc.
("MGI"), and others in support of a lawsuit that Oxford Nanopore intends to
file in the courts of England and Wales.

 

Oxford Nanopore anticipates bringing claims against BGI Tech Solutions Co.,
Ltd, BGI Group, BGI, Beijing Genomics Institute at Shenzhen, MGI Holdings Co.,
Limited and MGI Tech Co., Ltd in England for, inter alia, claims for breach of
contractual obligations, claims for breach of common law obligations of
confidence, breach of duties under the Trade Secrets (enforcement etc.)
Regulations 2018, and an entitlement claim to a license of certain
patents.  

 

Additionally, while not commenting on future litigation, the Group does not
believe BGI's nanopore-based sequencing technology is able to be used in
commercial products around the World without infringing or misappropriating
the Group's substantial portfolio of proprietary rights.

 

-ENDS-

 

For further information, please contact:

Oxford Nanopore Technologies plc

Investors:         ir@nanoporetech.com (mailto:ir@nanoporetech.com)

Media:              media@nanoporetech.com
(mailto:media@nanoporetech.com)

 

Teneo (communications adviser to the Company)

Tom Murray, Olivia Peters

+44 (0) 20 7353 4200

OxfordNanoporeTechnologies@teneo.com
(mailto:OxfordNanoporeTechnologies@teneo.com)

 

About Oxford Nanopore Technologies plc:

Oxford Nanopore Technologies' goal is to bring the widest benefits to society
through enabling the analysis of anything, by anyone, anywhere. The Group has
developed a new generation of nanopore-based sensing technology that is
currently used for real-time, high-performance, accessible, and scalable
analysis of DNA and RNA. The technology is used in more than 125 countries, to
understand the biology of humans, plants, animals, bacteria, viruses and
environments as well as to understand diseases such as cancer. Oxford
Nanopore's technology also has the potential to provide broad, high impact,
rapid insights in a number of areas including healthcare, food and
agriculture.

For more information please visit: www.nanoporetech.com
(http://www.nanoporetech.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUPUMPBUPCPGB